Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Seroprevalence of Coronavirus Disease 2019 (COVID-19) Among Health Care Workers from Three Pandemic Hospitals of Turkey

View ORCID ProfileGizem Alkurt, Ahmet Murt, Zeki Aydin, View ORCID ProfileOzge Tatli, Nihat Bugra Agaoglu, Arzu Irvem, Mehtap Aydin, Ridvan Karaali, Mustafa Gunes, Batuhan Yesilyurt, Hasan Turkez, Adil Mardinoglu, Mehmet Doganay, Filiz Basinoglu, Nurhan Seyahi, Gizem Dinler Doganay, View ORCID ProfileLevent Doganay
doi: https://doi.org/10.1101/2020.08.19.20178095
Gizem Alkurt
1Genomic Laboratory (GLAB), Umraniye Teaching and Research Hospital, University of Health Sciences, 34760, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gizem Alkurt
Ahmet Murt
2Department of Nephrology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, 34098, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zeki Aydin
3Department of Nephrology, Darica Farabi Teaching and Research Hospital, 41700, Kocaeli, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ozge Tatli
4Department of Molecular Biology and Genetics, Istanbul Technical University, 34467, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ozge Tatli
Nihat Bugra Agaoglu
1Genomic Laboratory (GLAB), Umraniye Teaching and Research Hospital, University of Health Sciences, 34760, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arzu Irvem
5Department of Microbiology, Umraniye Teaching and Research Hospital, University of Health Sciences, 34760, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mehtap Aydin
6Department of Infectious Disease, Umraniye Teaching and Research Hospital, University of Health Sciences, 34760, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ridvan Karaali
7Department of Infectious Disease, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, 34098, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mustafa Gunes
8Department of Urology, Darica Farabi Teaching and Research Hospital, 41700, Kocaeli, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Batuhan Yesilyurt
9Health Institutes of Turkey (TUSEB), 34718, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hasan Turkez
10Department of Medical Biology, Faculty of Medicine, Atatürk University, 25240, Erzurum, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adil Mardinoglu
11Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden
12Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King’s College London, London, SE1 9RT, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mehmet Doganay
13Department of Infectious Diseases, Erciyes University, 38039, Kayseri, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Filiz Basinoglu
14Department of Medical Biochemistry, Darica Farabi Teaching and Research Hospital, 41700, Kocaeli, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: levent.doganay{at}saglik.gov.tr gddoganay{at}itu.edu.tr nseyahi{at}yahoo.com fbasinoglu{at}yahoo.com
Nurhan Seyahi
2Department of Nephrology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, 34098, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: levent.doganay{at}saglik.gov.tr gddoganay{at}itu.edu.tr nseyahi{at}yahoo.com fbasinoglu{at}yahoo.com
Gizem Dinler Doganay
4Department of Molecular Biology and Genetics, Istanbul Technical University, 34467, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: levent.doganay{at}saglik.gov.tr gddoganay{at}itu.edu.tr nseyahi{at}yahoo.com fbasinoglu{at}yahoo.com
Levent Doganay
1Genomic Laboratory (GLAB), Umraniye Teaching and Research Hospital, University of Health Sciences, 34760, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Levent Doganay
  • For correspondence: levent.doganay{at}saglik.gov.tr gddoganay{at}itu.edu.tr nseyahi{at}yahoo.com fbasinoglu{at}yahoo.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

SUMMARY

COVID-19 is a global threat with an increasing number of infections. Research on IgG seroprevalence among health care workers (HCWs) is needed to re-evaluate health policies. This study was performed in three pandemic hospitals in Istanbul and Kocaeli. Different clusters of HCWs were screened for SARS-CoV-2 infection. Seropositivity rate among participants was evaluated by chemiluminescent microparticle immunoassay. We recruited 813 non-infected and 119 PCR-confirmed infected HCWs. Of the previously undiagnosed HCWs, 22 (2.7%) were seropositive. Seropositivity rates were highest for cleaning staff (6%), physicians (4%), nurses (2.2%) and radiology technicians (1%). Non-pandemic clinic (6.4%) and ICU (4.3%) had the highest prevalence. HCWs in “high risk group” had similar seropositivity rate with “no risk” group (2.9 vs 3.6 p=0.7), indicating the efficient implementation of protection measures in the hospitals in Turkey. These findings might lead to the re-evaluation of infection control and transmission dynamics in hospitals.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

We appreciate the generous contribution of Abbott for providing Architect SARS-CoV-2 IgG antibody kits, the chemiluminescence microparticle immunoassay method, to our institutions. We thank Yesim Karaca, Aleyna Karaca, Irem Yaren Nur and Murat Kaya for technical assistance. No external funding was received.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved by the ethics committee of the Umraniye Teaching and Research Hospital (approval number: 29.05.2020/10337). Written informed consent was obtained from each enrolled participant. All study was carried out in accordance with the ethical standards of the Helsinki Declaration.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Supporting information is available in supplementary files. No additional data are available.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted August 22, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Seroprevalence of Coronavirus Disease 2019 (COVID-19) Among Health Care Workers from Three Pandemic Hospitals of Turkey
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Seroprevalence of Coronavirus Disease 2019 (COVID-19) Among Health Care Workers from Three Pandemic Hospitals of Turkey
Gizem Alkurt, Ahmet Murt, Zeki Aydin, Ozge Tatli, Nihat Bugra Agaoglu, Arzu Irvem, Mehtap Aydin, Ridvan Karaali, Mustafa Gunes, Batuhan Yesilyurt, Hasan Turkez, Adil Mardinoglu, Mehmet Doganay, Filiz Basinoglu, Nurhan Seyahi, Gizem Dinler Doganay, Levent Doganay
medRxiv 2020.08.19.20178095; doi: https://doi.org/10.1101/2020.08.19.20178095
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Seroprevalence of Coronavirus Disease 2019 (COVID-19) Among Health Care Workers from Three Pandemic Hospitals of Turkey
Gizem Alkurt, Ahmet Murt, Zeki Aydin, Ozge Tatli, Nihat Bugra Agaoglu, Arzu Irvem, Mehtap Aydin, Ridvan Karaali, Mustafa Gunes, Batuhan Yesilyurt, Hasan Turkez, Adil Mardinoglu, Mehmet Doganay, Filiz Basinoglu, Nurhan Seyahi, Gizem Dinler Doganay, Levent Doganay
medRxiv 2020.08.19.20178095; doi: https://doi.org/10.1101/2020.08.19.20178095

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)